DC Longitudinal Study on Aging and Specimen Bank

Part of paid clinical trials in Washington D.C., District of Columbia.

Sponsor
Georgetown University
Study ID
NCT03702907
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
45 Years - N/A
Healthy Volunteers
Accepted

Study Details

The Georgetown University Memory Disorders Program, part of the Department of Neurology, is conducting pilot studies of the feasibility of various diagnostic tests for Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. Further, this study is assessing longitudinal changes in biological, lifestyle, and cognitive assessment collection. The primary goal of this study is to examine the feasibility of biochemical assays, genetic testing, and cognitive and lifestyle assessments in the ante-mortem diagnosis of Alzheimer's disease, mild cognitive impairment and other neurodegenerative diseases. This research involves genetic and cognitive status testing but the findings will not be shared with research subjects. This will be accomplished ex vivo using blood, and/or cerebrospinal fluid (CSF) specimens from patients with a diagnosis of probable Alzheimer's disease, mild cognitive impairment, or other neurodegenerative diseases and from normal controls.

Key Dates

Start date
Jan 1, 2007
Status verified
Oct 2019
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Normal Cognition
    No diagnosis of a cognitive disorder
  • Arm: Cognitive Disorder
    Diagnosed with a cognitive disorder such as :Mild Cognitive Impairment, Alzheimer's disease, Frontotemporal Dementia, Lewy Body Dementia, Vascular Dementia, or other neurodegenerative condition.

Primary Outcome Measure

CDR [ Time Frame: 9 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Georgetown University Memory Disorders ProgramWashington D.C.District of Columbia20057
Kelly McCann
202-687-0413

Find similar trials in Washington D.C., DC

Related Studies